CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (Nasdaq:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Henry E. Blair, Chairman, President and Chief Executive Officer of Dyax, will present at the Sixth Annual Needham Biotechnology and Medical Technology Conference, being held June 13-14 at The New York Palace in New York, NY. Mr. Blair will present a corporate progress report, including an update on the Company’s clinical development programs. The Dyax Corp. presentation is scheduled for Thursday, June 14 at 2:00 PM (ET).
